These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 22938126)

  • 1. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
    Goldstone P; Michelson J; Williamson E
    Med J Aust; 2012 Sep; 197(5):282-6. PubMed ID: 22938126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting.
    Goldstone P; Walker C; Hawtin K
    Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):366-371. PubMed ID: 28303569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial.
    Winikoff B; Dzuba IG; Creinin MD; Crowden WA; Goldberg AB; Gonzales J; Howe M; Moskowitz J; Prine L; Shannon CS
    Obstet Gynecol; 2008 Dec; 112(6):1303-1310. PubMed ID: 19037040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: report of a randomised trial.
    Creinin MD; Schwartz JL; Pymar HC; Fink W
    BJOG; 2001 May; 108(5):469-73. PubMed ID: 11368131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.
    Løkeland M; Iversen OE; Engeland A; Økland I; Bjørge L
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):647-53. PubMed ID: 24766569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending outpatient medical abortion services through 70 days of gestational age.
    Winikoff B; Dzuba IG; Chong E; Goldberg AB; Lichtenberg ES; Ball C; Dean G; Sacks D; Crowden WA; Swica Y
    Obstet Gynecol; 2012 Nov; 120(5):1070-6. PubMed ID: 23090524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia.
    Tsereteli T; Chong E; Louie K; Bokhua Z; Winikoff B
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):367-71. PubMed ID: 27449873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of mifepristone and misoprostol for the termination of pregnancy.
    ;
    Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone and misoprostol for early abortion when no gestational sac is present.
    Schaff EA; Fielding SL; Eisinger S; Stadalius L
    Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao.
    Boersma AA; Meyboom-de Jong B; Kleiverda G
    Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):61-6. PubMed ID: 21303309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion.
    Creinin MD; Potter C; Holovanisin M; Janczukiewicz L; Pymar HC; Schwartz JL; Meyn L
    Am J Obstet Gynecol; 2003 Mar; 188(3):664-9. PubMed ID: 12634638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.
    Schaff EA; Fielding SL; Westhoff C
    Contraception; 2001 Aug; 64(2):81-5. PubMed ID: 11704083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion.
    Chong E; Tsereteli T; Nguyen NN; Winikoff B
    Contraception; 2012 Sep; 86(3):251-6. PubMed ID: 22305917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days.
    Fjerstad M; Sivin I; Lichtenberg ES; Trussell J; Cleland K; Cullins V
    Contraception; 2009 Sep; 80(3):282-6. PubMed ID: 19698822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.